Straits Times Index
3,330.09 +11.64 (+0.35%) S&P 500
5,307.27 +2.55 (+0.05%) Dow
38,919.39 -150.20 (-0.38%) Nasdaq
17,000.88 +80.08 (+0.47%) Bitcoin USD
68,186.95 -2,049.78 (-2.92%) CMC Crypto 200
1,474.56 -21.90 (-1.46%)
EXAS Jul 2024 42.500 put
| Previous close | 0.6000 |
| Open | 1.1500 |
| Bid | 1.1000 |
| Ask | 1.2500 |
| Strike | 42.50 |
| Expiry date | 2024-07-19 |
| Day's range | 1.1000 - 1.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 253 |
Business WireExact Sciences to Participate in June Investor Conferences
MADISON, Wis., May 28, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.
Insider MonkeyHedge Funds are Bullish on This Cancer Stock
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in Exact Sciences Corporation (NASDAQ:EXAS). Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World […]
Business WireExact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
MADISON, Wis., May 24, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts highlighting the breadth and depth of the company’s screening and diagnostic portfolio at the American Society of Clinical Oncology® (ASCO®) Annual Meeting, taking place May 31 – June 4, 2024, in Chicago, Ill. Presentations will include new data confirming both the predictive and prognostic value of the Oncotype DX Breast Recurrence Score® test
